University Leipzig-Heart Center Leipzig, Strümpellstrasse 39, 4289 Leipzig, Germany.
Eur Heart J. 2013 Jun;34(24):1790-9. doi: 10.1093/eurheartj/eht111. Epub 2013 Apr 7.
On an empirical basis, exercise has been regarded as a fundamental pre-requisite for human well-being and physical integrity since classical times. Only in the last decades, however, scientific evidence has accumulated proving its role in the prevention and treatment of multiple chronic diseases beyond any reasonable doubt. Few treatment strategies in medicine have been tested so rigorously in large cohorts of patients as regular physical exercise. With the advent of molecular biology, the underlying mechanisms, such as NO bioavailability and mobilization of progenitor cells, could be identified. This enhances our understanding of this therapeutic tool. Unfortunately, the low compliance rate of the patients is the major drawback of the intervention exercise training (ET). The objective of this manuscript is to summarize the current knowledge with respect to ET on cardiovascular disease (CVD) and the molecular changes elicited by ET. Finally, we will critically assess reasons why ET as therapeutic option is not as effective at the population level in preventing CVD and what we may change in the future to make ET the most effective intervention to fight the development of CVD.
从古代开始,基于经验,运动就被视为人类幸福和身体健康的基本先决条件。然而,直到最近几十年,科学证据才不断积累,无可置疑地证明了运动在预防和治疗多种慢性疾病中的作用。在医学中,很少有治疗策略像定期体育锻炼那样在大量患者中进行如此严格的测试。随着分子生物学的出现,诸如 NO 生物利用度和祖细胞动员等潜在机制得以被识别。这增强了我们对这种治疗工具的理解。不幸的是,患者的低依从率是干预运动训练 (ET) 的主要缺点。本文的目的是总结关于 ET 对心血管疾病 (CVD) 的现有知识,以及 ET 引起的分子变化。最后,我们将批判性地评估为什么 ET 作为治疗选择在预防 CVD 方面在人群水平上没有那么有效,以及我们未来可能会做出哪些改变,以使 ET 成为对抗 CVD 发展的最有效干预措施。